Release of Hybrid Recon™ 3.0 with Full Collimator modelling
for high energy isotopes Y90, I131, I123 and Ho166
Stockholm - December 14 2018
Hermes Medical Solutions Releases Hybrid Recon™ 3.0, including Full Collimator modelling for high energy isotopes Y90, I131, I123 and Ho166.
Hybrid Recon™ provides absolute quantification at the point of clinical decision making for Theranostics and Personalized Dosimetry workflows such as SIRT.
This release also includes GPU based reconstruction, which reduces reconstruction time. At best, the GPU implementation has been observed to be 24 times faster than the multi-threaded CPU version on a 128 × 128 matrix size, 3 bed position, SPECT/CT bone study, when compensations for collimator and detector response, attenuation, and scatter were included.
Combined with attenuation correction from a hybrid SPECT-CT scanner or SPECT-only camera (utilizing an independent CT) and a Monte-Carlo modeled scatter correction, Hermes SUV SPECT® brings SPECT-CT systems from any vendor to the next level. This provides the foundation for use of these reconstructed quantitative studies in evidence based Precision Medicine, tailored treatment and follow-ups.
To learn more about the new Hybrid 3D™ and how Hermes is bringing Innovation for Referring Services and Treatment, visit us at booth #2165 during the RSNA meeting November 26th through December 1st 2017.
About Hermes Medical Solutions
Hermes Medical Solutions holds more than 40 years of recognition for Clinical Excellence and innovation in Molecular Imaging. Hermes delivers Enterprise Class systems and software for integrating, visualizing, processing and archiving imaging data from different imaging modalities and devices within Molecular Imaging and Radiology. Hermes solutions are empowering physicians by enabling a faster and more accurate diagnosis of patients, thereby improving quality and efficiency for healthcare provider’s clinical decision making.
Director Strategic Marketing